Skip to main content

The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".

Publication ,  Journal Article
Gonsalves, G; Yamey, G
Published in: BMJ (Clinical research ed.)
May 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMJ (Clinical research ed.)

DOI

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2021

Volume

373

Start / End Page

n1249

Related Subject Headings

  • General & Internal Medicine
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gonsalves, G., & Yamey, G. (2021). The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical Research Ed.), 373, n1249. https://doi.org/10.1136/bmj.n1249
Gonsalves, Gregg, and Gavin Yamey. “The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".BMJ (Clinical Research Ed.) 373 (May 2021): n1249. https://doi.org/10.1136/bmj.n1249.
Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical research ed). 2021 May;373:n1249.
Gonsalves, Gregg, and Gavin Yamey. “The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".BMJ (Clinical Research Ed.), vol. 373, May 2021, p. n1249. Epmc, doi:10.1136/bmj.n1249.
Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical research ed). 2021 May;373:n1249.

Published In

BMJ (Clinical research ed.)

DOI

EISSN

1756-1833

ISSN

0959-8138

Publication Date

May 2021

Volume

373

Start / End Page

n1249

Related Subject Headings

  • General & Internal Medicine
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences